Subscribe

Web Exclusives: Value-Based Care - November 2016

Enhanced molecular understanding of primary brain tumors has driven recent advances in treatment, which have extended beyond chemotherapy and radiotherapy to include immunomodulatory agents and electromagnetic fields applied directly to the scalp. Andrew B. Lassman, MD, Chief, Division of Neuro-Oncology, Columbia University Medical Center, New York, NY, provided an overview of the latest developments in the treatment of brain tumors at the 2016 American Academy of Neurology annual meeting.

Results 1 - 1 of 1
  • American Health & Drug Benefits
  • Lynx CME
  • Value-Based Care in Myeloma
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology